Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Theratechnologies Inc.

Theratechnologies Inc. (THTX) Stock Overview

Explore Theratechnologies Inc.’s financial performance, market position, analyst ratings, and future outlook.

THTX●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$3.39
$0.00(0.00%)
U.S. Market is Open · 13:55

Theratechnologies Inc. (THTX)

Meyka AI Score

Z

Key Financials

Market Cap155.9M
P/E Ratio-38.70
EPS (TTM)$-0.12
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$4.15

THTX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Theratechnologies Inc. (NASDAQ: THTX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Theratechnologies Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of THTX on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $4.15 for the NASDAQ listing.

Key metrics behind Theratechnologies Inc.'s NASDAQ-traded stock include a P/E ratio of -38.70 and a market capitalization of 155.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of THTX on the NASDAQ.

Price Performance (NASDAQ: THTX)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
6.94%
6-Month Change
22.38%
Year-to-Date (YTD) Change
84.24%
1-Year Change
175.61%
3-Year Change
-56.76%
5-Year Change
-58.25%
All-Time (Max) Change
-20.05%

Contact Information

https://www.theratech.com
15143367800
2015 Peel Street, Montreal, QC, H3A 1T8

Company Facts

1,030 Employees
IPO DateFeb 13, 2009
CountryCA

Frequently Asked Questions